Search

Issue
Title
Authors
ADJUVANT ANTI-HER2 THERAPY FOR BREAST CANCER
Semiglazov V.F., Semiglazov V.V., Ivanov V.G., Bessonov A.A., Shchedrin D.Y., Zhiltsova Y.K., Dashyan G.A., Paltuev R.M., Semiglazova T.Y., Penkov K.D., Vasilyev A.G., Semiglazov V.F., Semiglazov V.V., Ivanov V.G., Bessonov A.A., Shchedrin D.E., Zhil'tsova E.K., Dashyan G.A., Paltuev R.M., Semiglazova T.Y., Pen'kov K.D., Vasil'ev A.G.
Cardiotoxicity and chronic heart failure in the treatment of patients with gastric cancer: pathogenesis, methods of prevention and therapy
Astakhova Z.T., Zaseeva M.T.
Conversion therapy for disseminated gastric cancer. Interim results of a retrospective analysis of our own data
Besova N.S., Obarevich E.S., Tryakin A.A., Gavrilova D.A., Nered S.N., Kalinin A.E., Stilidi I.S.
Combination of sarcoidosis and sigmoid colon cancer: a clinical observation
Dmitrieva N.V., Mavlyavieva E.R., Chernikova Y.V., Fedotov E.V., Mirilashvili T.S.
Evaluation of immune response checkpoint dynamics in patients with lung cancer receiving immune therapy
Mochalova A.S.
Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Abdulaeva S.R., Semiglazova T.Y., Artemyeva A.S., Kudaibergenova A.G., Sharashenidze S.M., Tseluyko A.I., Paltuev R.M., Semiglazov V.V., Krivorotko P.V., Semiglazov V.F.
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
Zhukova L.G., Artamonova E.V., Ganshina I.P., Kolyadina I.V., Vorontsova K.A., Sekhina O.V., Grechukhina K.S.
Impact of nutritional deficiency and sarcopenia on the efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer: a retrospective study
Brish N.A., Semiglazova T.Y., Karachun A.M., Tkachenko E.V., Artemieva A.S., Shevkunov L.N., Ulyanchenko Y.A., Golovanova T.S., Alekseeva Y.V., Sharashenidze S.M., Strakh L.V., Filatova L.V., Semiglazov V.V., Kasparov B.S., Protsenko S.A., Belyaev A.M.
Prevention of colorectal cancer in patients with inflammatory bowel disease
Bikbavova G.R., Livzan M.A., Fedorin M.M.
Endocrine resistance in breast cancer treatment
Dzhelyalova M.A., Semiglazov V.F.
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis
Fateeva A.V., Zyuzyukina A.V., Zukov R.A.
Assessment of intensified neoadjuvant chemotherapy regimens for locally advanced cervical cancer
Smirnova O.A., Bondarev N.E., Ulrikh E.A., Mikaya N.A., Kotiv K.B., Petrova A.S., Ivantsov A.O., Gorodnova T.V., Nekrasova E.A., Lavrinovich O.E., Yakovleva M.G., Abramova A.V., Malyutina D.V., Parsyan S.G., Mkrtchyan G.B., Ibragimov Z.N., Trifanov Y.N., Sidoruk A.A., Urmancheeva A.F., Berlev I.V.
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
Belyak N.P., Kutukova S.I., Orlova R.V., Zhukova N.V., Erdniev S.P., Zorina E.Y., Avramenko I.V., Antimonik N.Y., Popova N.V., Ivanova A.K., Androsova A.V.
Potentials of drug therapy for metastatic/recurrent cervical cancer
Ulrikh E.A., Semiglazova T.Y., Khalimbekova D.I., Smirnova O.A., Ulrikh D.G., Urmancheeva A.F.
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D.D., Iskhakova A.I., Kunafina R.I.
Modern approaches to the diagnosis and treatment of acute pyelonephritis in patients with bladder cancer
Kaprin A.D., Kostin A.A., Vorobyev N.V., Popov S.V.
GASTRIC MICROBIOTA AND POTENTIALS OF PROBIOTICS IN THE ERADICATION OF H. PYLORI
Kornienko E.A., Parolova N.I.
Chemotherapy of endometrial cancer -E.V. Bakhidze, A.V. Belyaeva 29 Optimal tactics of adjuvant treatment of patients with endometrial cancer
Khokhlova S.V., Bazaeva I.Y.
CLINICAL OBSERVATION OF RARE METASTASIS OF GASTRIC ADENOCARCINOMA TO THE PENIS
Trusilova E.V., Ivanov A.M., Besova N.S., Skvortsov I.Y., Tsymzhitova N.T.
LONG-TERM RESULTS OF SECOND LINE ANTICANCER THERAPY OF METASTATIC COLORECTAL CANCER AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS
Vorontsova K.A., Chemoglazova E.V., Rotobelskaya L.E., Vyshinskaya G.V.
ALK-pozitivnyy nemelkokletochnyy rak legkogo i metody ego lecheniya: obzor literatury
Laktionov K.K., Reutova E.V., Sarantseva K.A.
NOVYY MEZhDUNARODNYY (KIOTSKIY) KONSENSUS PO VEDENIYu PATsIENTOV S GASTRITOM
Tsukanov V.V., Kasparov E.V., Vasyutin A.V., Onuchina E.V., Tonkikh Y.L.
Kompleksnoe lechenie bol'nykh s tserebral'nymi metastazami kolorektal'nogo raka
Karakhan V.B., Naskhletashvili D.R., Mitrofanov A.A.
EVEROLIMUS (AFINITOR): NOVYE VOZMOZhNOSTI TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Gorbunova V.A.
Osobennosti predoperatsionnoy podgotovki i vedeniya bol'nykh kolorektal'nym rakom starcheskogo vozrasta
Markar'yan D.R., Tsar'kov P.V., Minnibaeva E.R.
GORMONAL'NAYa TERAPIYa RAKA PREDSTATEL'NOY ZhELEZY
Chernyaev V.A.
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
Zhukova L.G., Lichinitser M.R.
PREVALENCE AND PRINCIPLES OF TREATMENT OF BARRETT'S ESOPHAGUS
Maev I.V., Tsukanov V.V., Butorin N.N., Kasparov E.V., Bichurina T.B., Vasyutin A.V., Maev I.V., Tcukanov V.V., Butorin N.N., Kasparov E.V., Bichurina T.B., Vasyutin A.V.
MALIGNANT TUMORS OF URINARY BLADDER
Pavlov V.N., Izmaylov A.A., Izmaylova S.M., Mustafin A.T., Galimzyanov V.Z., Urmantsev M.F., Pavlov V.N., Ismaylov A.A., Ismaylova S.M., Mustafin A.T., Galimzyanov V.Z., Urmancev M.F.
BONE METABOLISM AND EFFECTIVENESS OF ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
Glybochko P.V., Alyaev Y.G., Vinarov A.Z., Demidko Y.L., Zelenova O.V., Shpot' E.V., Glybochko P., Alyaev Y.G., Vinarov A.Z., Demidko Y.L., Zelenova O.V., Shpot Y.V.
RESORBA IN THE TREATMENT OF BONE METASTASIS OF BREAST CANCER
Vladimirova L.Y., Abramova N.A., E Storozhakova A., Paly A.L., Vladimirova L.Y., Abramova N.A., Storozhakova A.E., Paliy A.L.
NEOADJUVANT THERAPY OF THE BREAST CANCER WITH HIGH EXPRESSION OF HER-2
Semiglazov V.F., Manikhas A.G., Bozhok A.A., Dashjan G.A., Vasilev A.G., Petrovsky S.G., Matsko D.Y., Semiglazov V.V., Paltuev R.M., Ivanov V.G., Zernov K.Y., Donskikh R.V., Bessonov A.A., Shamina Y.A., Semiglazov V.F., Manikhas A.G., Bozhok A.A., Vasil'ev A.G., Petrovskiy S.G., Matsko D.E., Semiglazov V.V., Dashyan G.A., Paltuev R.M., Ivanov V.G., Zernov K.Y., Donskikh R.V., Bessonov A.A., Shamina E.A.
Case report: long-term response to osimertinib in metastatic non-small cell lung cancer with a rare mutation in EGFR gene exon 20
Nelyubina L.A., Reutova E.V., Laktionov K.K., Stroganova A.M.
Adherence to adjuvant hormonal therapy for luminal HER2-negative breast cancer: results of a patient survey
Gordeeva O.O., Bokova S.E.
Data in the treatment of colon cancer from real clinical practice in Tashkent, Uzbekistan
Khakimova G.G., Tryakin A.A.
Possibilities of overcoming hormone resistance in patients with metastatic HR+ HER2- breast cancer using the drug alpelisib in various subgroups in real clinical practice
Orlova R.V., Gluzman M.I., Vakhitova A.A.
Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Pesotsky R.S., Semiglazov V.F., Krivorotko P.V., Tabagua T.T., Zernov K.Y., Emelyanov A.S., Yerechshenko S.S., Amirov N., Mortada V.V., Ulrikh D.G., Levchenko V.E., Rychagov K.Y., Zirov K.Y., Evseev V.N.
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
Golubenko E.O., Savelyeva M.I., Sozaeva Z.A., Poddubnaya I.V., Korennaya V.V.
Clinical immunology of breast cancer
Tseluiko A.I., Semiglazov V.F., Kudaibergenova A.G., Artemyeva A.S., Paltuev R.M., Donskikh R.V., Pesotsky R.S., Krivorotko P.V.
Neoadjuvant immunotherapy for non-small cell lung cancer
Semenova A.I., Protsenko S.A., Teletaeva G.M., Latipova D.K., Novik A.V.
Optimization of the tactics of adjuvant chemotherapy in patients with colon cancer taking into account clinical and morphological characteristics
Ivanova A.K., Orlova R.V., Raskin G.A., Kutukova S.I.
Rare case of pheochromocytoma with calcitonin hypersecretion
Rebrova D.V., Rusakov V.F., Fedorov E.A., Krasnov L.M., Vorokhobina N.V., Shikhmagomedov S.S., Vorobyev S.L., Sleptsov I.V., Chernikov R.A., Savelyeva T.V., Semenov A.A., Chinchuk I.K., Sablin I.V., Pridvizhkina T.S., Fedotov Y.N.
Optimal treatment strategy for a patient with advanced ovarian cancer without deterioration in the quality of life: a clinical case
Khokhlova S.V.
Influence of FOLFIRINOX on the achievement of resistability in patients with rectal and liver metastases
Khakimov G.A., Dzhumaniezov K.I., Kadyrov S.S., Khakimova G.G., Abdulkhuseynova S.I., Poluzhkina I.N.
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
Buevich N.N., Protsenko S.A., Nosov A.K., Reva S.A., Artemyeva A.S., Berkut M.V.
Current aspects of the treatment of BRCA-associated ovarian cancer
Rumyantsev A.A.
INTERCELLULAR ADHESION MOLECULES (E-CADHERIN, ß-CATENIN) IN COLORECTAL CANCER: CHARACTERISTICS; ROLE IN MECHANISMS OF TUMOR INVASION, METASTASIS AND REGULATION OF TUMOR PROGRESSION; INFLUENCE ON PROGNOSIS (LITERATURE REVIEW)
Darenskay A.D., Dobrova N.V., Stepanova E.V.
Skin melanoma in practice of dermatologist
Sergeev Y.Y., Mordovtseva V.V., Sergeev V.Y.
Ixempra - new possibilities of cytostatic therapy of breast cancer
Lubennikova E.V., Zhukova L.G., Arutyunyan E.A.
Cashuistic case of treatment of discemned small-cell lung cancer
Khakimova G.G., Titova T.A., Kuzminov A.E., Gorbunova V.A., Delektorskaya V.V., Borisova T.N.
METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
Abramov M.E., Bardovskaya K.S., Mescheryakov A.A., Medvedeva B.M.
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD
Zhukova L.G., Manikhas A.G.
TARGETED THERAPY IN COMPLEX TREATMENT OF RENAL CANCER PATIENTS WITH BRAIN METASTASES
Naskhletashvili D.R.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K.A., Dobrova N.V., Vyshinskaya G.V.
Issledovanie faktorov rosta pri razlichnykh zabolevaniyakh predstatel'noy zhelezy
Kostin A.A., Andryukhin M.I., Pul'bere S.A., Motin P.I., Agaev N.K.
Opyt lecheniya bol'nykh metastazami kolorektal'nogo raka: irinotekan+raltitreksed (2-ya liniya khimioterapii)
Vorontsova K.A., Dobrova N.V., Vakhabova Y.V., Vyshinskaya G.V.
ALK-POZITIVNYY NEMELKOKLETOChNYY RAK LEGKOGO: NOVYE PATsIENTY I NOVYE VOZMOZhNOSTI LEKARSTVENNOGO LEChENIYa
Breder V.V., Laktionov K.K.
Gormonoterapiya metatstaticheskogo i retsidivnogo raka endometriya
Bakhidze E.V.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.G.
Hormonal treatment of breast cancer: optimal sequence and issues of overcoming the resistance
Borisova E.I., Gutorov S.L., Vorontsov A.Y.
Current potentials for the drug therapy of adrenocortical cancer
Filimonyuk A.V.
VEDENIE PATsIENTOV S KhRONIChESKIMI VIRUSNYMI GEPATITAMI I ONKOLOGIChESKOY PATOLOGIEY
Bogomolov P.O., Bueverov A.O., Matsievich M.V., Voronkova N.V., Kokina K.Y., Koblov S.V., Trofimova M.N.
CLINICAL EXPERIENCE OF USE OF BEVACIZUMAB (AVASTIN) IN PATIENTS WITH METASTATIC BREAST CANCER WITH UNIDENTIFIED HER2/NEW AND ER PR-RECEPTOR STATUS
Konstantinova M.M., Shikina V.E., Makshantsev A.Y., Konstantinova M.M., Shikina V.Y., Makshantsev A.Y.
DRUG ZOMETA IN ADDITION TO THE CHEMOTHERAPY SIGNIFICANTLY INCREASES OVERALL SURVIVAL IN PREVIOUSLY UNTREATED PATIENTS WITH MULTIPLE MYELOMA
Zhukov N.V., Zhukov N.V.
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CRYPTORCHIDISM UNDER PRESENT-DAY CONDITIONS
Hamidov S., Ovchinnikov R., Myasnikov D., Pavlovichev A., Tazhetdinov O., Tkhagapsoeva R., Gamidov S.o., Ovchinnikov R.I., Myasnikov D.A., Pavlovichev A.A., Tazhetdinov O.K., Tkhagapsoeva R.A.
Potentials for endoscopic and magnetic resonance diagnostic methods in assessing the radicality of chemoradiotherapy in patients with rectal cancer
Salimova A.A., Makarova M.V., Besova N.S., Kuvshinov Y.P., Karasev I.A.
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
Ivanova F.G., Nikolaeva T.I., Spiridonova N.I., Afanasyeva L.N., Nikiforov P.V., Zharnikova T.N.
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
Gulian I.S., Bystritskaya E.P., Otstavnykh N.Y., Khudchenko E.V., Eliseeva E.V., Apanasevich V.I., Isaeva M.P.
Ixabepilone in the treatment of breast cancer
Semiglazov V.F., Krivorotko P.V., Semiglazova T.Y., Komyakhov A.V., Tabagua T.T., Kazantseva M.D., Zhiltsova E.K., Ulrikh D.G., Chervyak M.V., Tergoeva A.P., Klimenko V.V., Semiglazov V.V.
Diagnosis of HPV-associated cervical diseases in postmenopausal women. Problems and solutions
Dovletkhanova E.R.
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg
Kulakova A.S., Bentsion D.L., Elishev V.G., Vetrov V.A.
Sentinel lymph node scintigraphy in breast cancer. Own experience
Afanasyeva N.G., Vazhenin A.V., Trofimchuk L.Y., Chvanova K.V.
A unique case of colon cancer metastasis treatment. A case from practice
Khakimova G.G., Islamov F.S., Khakimov G.A.
Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Semiglazova T.Y., Volynshchikova O.A., Semiglazov V.V., Klimenko V.V., Brish N.A., Alekseeva Y.V., Klyuge V.A., Krutov A.A., Paltuev R.M., Kasparov B.S., Krivorotko P.V., Semiglazov V.F.
Primary multiple colonic tumors of various genetic characteristics in a patient with familial adenomatous polyposis: description of the clinical case
Gutorov S.L., Borisova E.I., Ivanova K.A., Manukyan M.S., Abdulkhuseinova S.I.
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of BRCA1-associated ovarian cancer
Kotiv K.B., Yakovleva M.G., Sokolenko A.P., Gorodnova T.V., Ivantsov A.O., Nekrasova E.A., Smirnova O.A., Sidoruk A.A., Bondarev N.E., Meshkova I.E., Mikaya N.A., Petrik S.V., Urmancheeva A.F., Ulrikh E.A., Protsenko S.A., Belyaev A.M., Imyanitov E.N., Berlev I.V.
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
Semiglazova T.Y., Sorokina I.V.
RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
Titova T.A., Besova N.S., Gorbunova V.A., Fedenko A.A., Malikhova O.A.
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Semiglazova T.Y., Berlev I.V., Ulrikh E.A., Semiglazov V.V., Protasova A.E., Brish N.A., Korobeynikova E.A., Alekseeva Y.V., Filatova L.V., Semenova A.I., Latipova D.K., Teletaeva G.M., Tkachenko E.V., Klimenko V.V., Dashyan G.A., Protsenko S.A., Paltuev R.M., Urmancheeva A.F., Krivorotko P.V., Semiglazov V.F.
Prognostic values of the presence of disseminated tumor cells in the bone marrow in patients with disseminated stomach cancer before start of treatment with antitumor drugs
Besova N.S., Obarevich E.S., Davydov M.M., Beznos O.A., Tupitsyn N.N.
ONCOMODULATING EFFECT OF CYTOMEGALOVIRUS IN BLADDER CANCER: MYTH OR REALITY?
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Pogodina I.E., Kolbasov D.N.
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
Dobrova N.V., Borisova E.I., Gutorov S.L., Abramov M.E.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A.I., Protsenko S.A., Novik A.V., Latipova D.H., Teletayeva G.M., Semiglazova T.Y.
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
Vorontsova K.A., Zhukova L.G.
Struktura slizistoy obolochki zheludka u bol'nykh rakom zheludka v Respublike Khakasiya
Tsukanov V.V., Kasparov E.V., Butorin N.N., Shtygasheva O.V., Vasyutin A.V., Amel'chugova O.S., Tonkikh Y.L., Bronnikova E.P.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Dashyan G.A., Paltuev R.M.
Novye metody terapii v lechenii kastratsionnorezistentnogo raka predstatel'noy zhelezy
Sokov D.G.
SOVREMENNYE PODKhODY K LEKARSTVENNOY TERAPII BOL'NYKh METASTATIChESKIM KASTRATsIONNO-REFRAKTERNYM RAKOM PREDSTATEL'NOY ZhELEZY
Kaprin A.D., Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S.
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Semiglazova T.Y., Semiglazov V.V., Filatova L.V., Krivorot'ko P.V., Klimenko V.V., Ivanov V.G., Novikov S.M., Gershanovich M.L., Imyanitov E.N., Semiglazov V.F.
NASTOYaShchEE I BUDUShchEE TARGETNOY TERAPII V PERVOY LINII LEChENIYa RAKA YaIChNIKOV
Tyulyandina A.S.
A new approach to the overcoming resistance to hormone therapy of breast cancer
Semiglazova T.Y., Semiglazov V.V., Filatova L.V., Krivorot'ko P.V., Klimenko V.V., Gershanovich M.L., Semiglazov V.F.
Khronicheskiy gastrit: kak preodolet' kompleks neopredelennosti?
Khomeriki N.M., Khomeriki S.G.
SKRININGOVOE OBSLEDOVANIE BOL'NYKh S KhRONIChESKIMI ZABOLEVANIYaMI PEChENI DLYa VYYaVLENIYa RANNIKh STADIY GEPATOTsELLYuLYaRNOGO RAKA
Zinatulin D.R., Trandofilov M.M., Shevchenko V.P., Vedeneev A.A.
TARGETED THERAPY AFTER PROGRESSION OF HER-2-POSITIVE BREAST CANCER
Tat'yana Y.S., Semiglazov V.V., Larisa V.F., Chubenko V.A., Nikita V.B., Fedor V.M., Latipova D.K., Mikhail L.G., Semiglazova T.Y., Semiglazov V.V., Filatova L.V., Chubenko V.A., Brejnev N.V., Moiseenko F.V., Latipova D., Gershanovich M.L.
RISK-ASSOCIATED THERAPY OF MUSCULAR-NONINVASIVE BLADDER CANCER
Golovashchenko M.P., Rusakov I.G., Golovaschenko M.P., Rusakov I.G.
MAINTENANCE THERAPY IN STAGES IIIB-IV NON-SMALL-CELL LUNG CANCER
Gutorov S.L., Borisova Y.I., Gutorov S.L., Borisova E.I.
Prophylaxis of cervical cancer
Prilepskaya V.N., Bebneva T.N., Prilepskaya V., Bebneva T.
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
Fateeva A.V., Eliseeva E.V., Apanasevich V.I., Zaemskaya A.A.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
Romashkina N.V., Klishina M.V., Karabina E.V.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D.A., Besova N.S., Obarevich E.S., Makiev G.G., Tryakin A.A., Stilidi I.S.
101 - 200 of 294 Items << < 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"